USP18 promotes the growth in hemangiomas by regulating PI3K/AKT pathway-Reference-Cited by-同舟云学术

USP18 promotes the growth in hemangiomas by regulating PI3K/AKT pathway

Published:2021-06-11 Issue:4 Volume:17 Page:409-416
ISSN:1738-642X
Container-title:Molecular & Cellular Toxicology
language:en
Short-container-title:Mol. Cell. Toxicol.

Author:

Ke Huan,Ma Xiang^ORCID,Zeng Ying,Lu Jingjing,Fu Guili

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,General Pharmacology, Toxicology and Pharmaceutics,Toxicology,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13273-021-00146-5.pdf

Reference27 articles.

1. Burkart C et al (2013) Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10. EMBO Mol Med 5:1035–1050. https://doi.org/10.1002/emmm.201201864

2. Burks J, Reed RE, Desai SD (2014) ISGylation governs the oncogenic function of Ki-Ras in breast cancer. Oncogene 33:794–803. https://doi.org/10.1038/onc.2012.633

3. Calicchio ML, Collins T, Kozakewich HP (2009) Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling. Am J Pathol 174:1638–1649. https://doi.org/10.2353/ajpath.2009.080517

4. Chang L et al (2008) Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 122:360–367. https://doi.org/10.1542/peds.2007-2767

5. Diao W et al (2020) USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway. BMC Cancer 20:741–741. https://doi.org/10.1186/s12885-020-07241-1